Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps.
Camb Q Healthc Ethics
; 30(1): 51-58, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1047906
ABSTRACT
While the world rushed to develop treatments for COVID-19, some turned hopefully to drug repurposing (drug repositioning). However, little study has addressed issues of drug repurposing in emergency situations from a broader perspective, taking into account the social and ethical ramifications. When drug repurposing is employed in emergency situations, the fairness of resource distribution becomes an issue that requires careful ethical consideration.This paper examines the drug repurposing in emergency situations focusing on the fairness using Japanese cases. Ethical issues under these circumstances addressed by the authors include maintaining the evidence level, integrity of clinical research ethics, and voluntary consent by original indication patients. In order to address these issues, they argue that rapid accumulation of ethically and scientifically valid evidence is required, as is obtaining information on resource quantity.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Reposicionamiento de Medicamentos
/
Tratamiento Farmacológico de COVID-19
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Camb Q Healthc Ethics
Asunto de la revista:
Etica
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS